行情

APVO

APVO

Aptevo
NASDAQ

实时行情|Nasdaq Last Sale

0.5865
-0.0258
-4.21%
休市 16:00 12/13 EST
开盘
0.6100
昨收
0.6123
最高
0.6180
最低
0.5700
成交量
32.11万
成交额
--
52周最高
2.000
52周最低
0.4900
市值
2,655.63万
市盈率(TTM)
-0.4065
分时
5日
1月
3月
1年
5年

分析师评级

3位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

APVO 新闻

  • 澳政府下调经济及工资增长预期
  • 新浪财经.1小时前
  • IFF将与杜邦营养及生物科技业务合并 市值450亿美元
  • 新浪财经.1小时前
  • 波音将决定进一步减产或停产737 Max客机
  • 新浪财经.1小时前
  • 阿里巴巴张勇获颁 第一财经“2019杰出商界领军者”
  • 第一财经.4小时前

更多

所属板块

生物技术和医学研究
+1.07%
制药与医学研究
-0.32%

热门股票

名称
价格
涨跌幅

APVO 简况

Aptevo Therapeutics Inc. is a biotechnology company. The Company is focused on oncology and hematology therapeutics. The Company is engaged in the discovery, development, commercialization and sale of oncology and hematology therapeutics. The Company's technology is the ADAPTIR (modular protein technology) platform. The Company has approximately four products in the areas of hematology and infectious diseases, as well as various investigational-stage product candidates in immuno-oncology. The Company's investigational-stage product candidates include MOR209/ES414, ES210, ES425, Otlertuzumab and 5E3. Its technology can produce monospecific and multispecific immunotherapeutic proteins that bind to various targets. The Company's marketed products are WinRho SDF (Rho(D) Immune Globulin Intravenous (Human)), HepaGam B (Hepatitis B Immune Globulin Intravenous (Human)), VARIZIG (Varicella Zoster Immune Globulin (Human)), and IXINITY (coagulation factor IX (recombinant)).
展开

Webull提供Aptevo Therapeutics Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。